Boston Scientific has claimed a new approval from the FDA for its Farapulse pulsed field ablation system, expanding its use ...

Marlborough: Boston Scientific Corporation has announced that the company has received approval from the U.S. Food and Drug ...

Boston Scientific receives US FDA approval for expanded labelling of Farapulse PFA System: Marlborough, Massachusetts Tuesday, July 8, 2025, 11:00 Hrs [IST] Boston Scientific Corp ...

The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation MARLBOROUGH, Mass., July 7, ...

Boston Scientific Corp. gained a second U.S. FDA approval for its Farapulse pulsed field ablation catheter, expanding its use into drug-refractory, symptomatic persistent atrial fibrillation (AF) in ...

Undeniably, Barchart’s screener for unusual stock options volume is an important tool for deciphering market sentiment, ...

The stock's fall snapped a six-day winning streak.

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2025, on Wednesday, July 23 ...

With a market cap of $154.3 billion, Boston Scientific Corporation (BSX) is a global developer, manufacturer, and marketer of ...

Boston Scientific Down Over 7%, on Pace for Largest Percent Decrease Since November 2020 — Data Talk Global News Select Apr 4, 2025, 9:41:00 AM ...

Boston Scientific Corp Boston Scientific Corp BSX Stock XNYS Rating as of Jul 4, 2025 Read Company Report Download PDF ...